A phase I/II study of the protease inhibitor indinavir in children with HIV infection.
Mueller BU, Sleasman J, Nelson RP Jr, Smith S, Deutsch PJ, Ju W, Steinberg SM, Balis FM, Jarosinski PF, Brouwers P, Mistry G, Winchell G, Zwerski S, Sei S, Wood LV, Zeichner S, Pizzo PA.
Mueller BU, et al.
Pediatrics. 1998 Jul;102(1 Pt 1):101-9. doi: 10.1542/peds.102.1.101.
Pediatrics. 1998.
PMID: 9651421
Clinical Trial.